Methylation of the imidazole side chains of the alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity
FOXO4-DRI has three main pharmacogenetic advantages: its stability (resistance to degradation by cellular proteases), half-life (compared to L-peptide equivalents, it's longer), and cell-penetrating properties (cell-penetrating sequences improve intracellular delivery)
This is where things get critical, and it is something that far too many people overlook
However, it can severely reduce quality of life and may present the risk of serious complications when left untreated
excess is renally excreted, though very high levels can cause dermatologic or metabolic effects
Immunity 28 , 687697 (2008)